High-throughput transfection and engineering of primary cells and cultured cell lines - An invaluable tool for research as well as drug development

Expert Opinion on Drug Discovery

Volumn 2, Issue 11, 2007, Pages 1453-1465

  Müller Hartmann, Herbert ^a   Faust, Nicole ^a   Kazinski, Michael ^a   Kretzschmar, Titus ^a  

^a Amaxa GmbH   (Germany)

Author keywords

Cell engineering; Cell based assay; Eukaryotic cell; Gene therapy; High throughput; Molecule delivery; Primary cell; Protein expression; Protein production; Transduction; Transfection

Indexed keywords

COMPLEMENTARY DNA; LENTIVIRUS VECTOR; NUCLEIC ACID; PEPTIDE; PLASMID DNA; REAGENT; RETROVIRUS VECTOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

ADOPTIVE IMMUNOTHERAPY; CELL CULTURE; CELL LINE; DRUG RESEARCH; ELECTROPORATION; EUKARYOTIC CELL; GENE IDENTIFICATION; GENE LIBRARY; GENE THERAPY; GENETIC TRANSFECTION; HIGH THROUGHPUT SCREENING; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VALIDATION PROCESS; VIRAL GENE DELIVERY SYSTEM;

EID: 36549019575     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460441.2.11.1453     Document Type: Review

References (107)

1. MCCUTCHAN JH, PAGANO JS: Enhancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran. J. Natl. Cancer Inst. (1968) 41(2):351-357.
2. WARDEN D, THORNE HV: The infectivity of polyoma virus DNA for mouse embryo cells in the presence of diethylaminoethyl-dextran. J. Gene Virol. (1968) 3(3):371-377.
3. GRAHAM FL, VAN DER EB AJ: A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 52(2):456-467.
4. HAMER DH, LEDER P: Expression of the chromosomal mouse β maj-globin gene cloned in SV40. Nature (1979) 281(5726):35-40.
5. MULLIGAN RC, HOWARD BH, BERG P: Synthesis of rabbit β-globin in cultured monkey kidney cells following infection with a SV20 β-globin recombinant genome. Nature (1979) 277(5692):108-114.
6. FRALEY R, SUBRAMANI S, BERG P, PAPAHADJOPOULOS D: Introduction of liposome-encapsulate SV40 DNA into cells. J. Biol. Chem. (1980) 255(21):10431-10435.
7. MUKHERJEE AB, ORLOFF S, BUTLER JD, TRICHE T, LALLEY P, SCHULMAN JD: Entrapment of metaphase chromosomes into phospholipid vesicles (lipochromosomes): carrier potential in gene transfer. Proc. Natl. Acad. Sci. USA (1978) 75(3):1361-1365.
8. WONG TK, NICOLAU C, HOFSCHNEIDER PH: Appearance of β-lactamase activity in animal cells upon liposome-mediated gene transfer. Gene (1980) 10(2):87-94.
9. NEUMANN E, SCHAEFER-RIDDER M, WANG Y, HOFSCHNEIDER PH: Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J. (1982) 1(7):841-845.
10. ZIAUDDIN J, SABATINI DM: Microarrays of cells expressing defined cDNAs. Nature (2001) 411(6833):107-110.
11. RINES DR, TU B, MIRAGLIA L et al.: High-content screening of functional genomic libraries. Methods Enzymol. (2006) 414:530-565.
12. STEINBERG TH, NEWMAN AS, SWANSON JA, SILVERSTEIN SC: ATP4-permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes. J. Biol. Chem. (1987) 262(18):8881-8888.
13. 1 cells subjected to electroporation. Antimicrob. Agents Chemother. (2006) 50(4):1213-1221.
14. CHAKRABARTI R, WYLIE DE, SCHUSTER SM: Transfer of monoclonal antibodies into mammalian cells by electroporation. J. Biol. Chem. (1989) 264(26):15494-15500.
15. LUKAS J, BARTEK J, STRAUSS M: Efficient transfer of antibodies into mammalian cells by electroporation. J. Immunol. Methods (1994) 170(2):255-259.
16. FOTIN-MLECZEK M, WELTE S, MADER O et al.: Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization. J. Cell Sci. (2005) 118(15):3339-3351.
17. WAIZENEGGER T, FISCHER R, BROCK R: Intracellular concentration measurements in adherent cells: a comparison of import efficiencies of cell-permeable peptides. Biol. Chem. (2002) 383(2):291-299.
18. BAILEY SN, ALI SM, CARPENTER AE, HIGGINS CO, SABATINI DM: Microarrays of lentiviruses for gene function screens in immortalized and primary cells. Nat. Methods (2006) 3(2):117-122.
19. BUMCROT D, MANOHARAN M, KOTELIANSKY V, SAH DW: RNAi therapeutics: a potential new class of pharmaceutical drugs. Natl. Chem. Biol. (2006) 2(12):711-719.
20. ECHEVERRI CJ, PERRIMON N: High-throughput RNAi screening in cultured cells: a users guide. Nat. Rev. Genet. (2006) 7(5):373-384.
21. LLANOS S, EFEYAN A, MONSECH J, DOMINGUEZ O, SERRANO M: A high-throughput loss-of-function screening identifies novel p53 regulators. Cell Cycle (2006) 5(16):1880-1885.
22. PALMER E, FREEMAN T: Cell-based mscroarrays: current progress, future prospects. Pharmacogenomics (2005) 6(5):527-534.
23. PEARLBERG J, DEGOT S, ENDEGE W et al.: Screens using RNAi and cDNA expression as surrogates for genetics in mammalian tissue culture cells. In: Cold Spring Harbor Symposia on Quantitative Biology (Volume LXX). Cold Spring Harbor Laboratory Press (2005):449-459.
24. YU DH, CHATTERTON JE, BLIESATH JR et al.: A 96-well surrogate survival assay coupled with a special short interfering RNA vector for assessing cancer gene targets with enhanced signal/noise ratio and its utility in HTS for cancer therapeutic targets. ASSAY Drug Dev. Technol. (2005) 3(4):401-411.
25. ZHENG L, LIU J, BATALOV S et al.: An approach to genomewide screens of expressed small interfering RNAs in mammalian cells. Proc. Natl. Acad. Sci. USA (2004) 101(1):135-140.
26. KORHERR C, GILLE H, SCHÄFER R et al.: Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway. Proc. Natl. Acad. Sci. USA (2006) 103(11):4240-4245.
27. PALMER E, MILLER AD, FREEMAN TC: Identification and characterization of human apoptosis inducing proteins using cell-based transfection microarrays and expression analysis. BMC Genomics (2006) 7:145.
28. MACDONALD ML, LAMERDIN J, OWENS S et al.: Identifying off-target effects and hidden phenotypes of drugs in human cells. Nat. Chem. Biol. (2006) 2(6):329-337.
29. DELEHANTY JB, SHAFFER KM, LIN B: Transfected cell microarrays for the expression of membrane-displayed single-chain antibodies. Anal. Chem. (2004) 76(24):7323-7328.
30. BAILEY SN, SABATINI DM, STOCKWELL BR: Microarrays of small molecules embedded in biodegradable polymers for use in mammalian cell-based screens. Proc. Natl. Acad. Sci. USA (2004) 101(46):16144-16149.
31. MOFFAT J, GRUENEBERG DA, YANG X et al.: A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell (2006) 124(6):1283-1298.
32. CHAPPLE SDJ, CROFTS AM, SHADBOLT SP, MCCAFFERTY J, DYSON MR: Multiplexed expression and screening for recombinant protein production in mammalian cells. BMC Biotech. (2006) 6:49-64.
33. HARPER SQ, STABER PD, BECK CR et al.: Optimization of feline immunodeficiency virus vectors for RNA interference. J. Virol. (2006) 80(19):9371-9380.
34. WRIGHT A, SEMYONOV A, DAWES G et al.: Diverse plasmid DNA vectors by directed molecular evolution of cytomegalovirus promoters. Hum. Gene Ther. (2005) 16(7):881-891.
35. ARICESCU AR, LU W, JONES EY: A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr. D. Biol Crystallogr. (2006) 62:1243-1250.
36. LOOMIS KH, YAEGER KW, BATENJANY MM et al.: InsectDirect™ system: rapid, high-level protein expression and purification from insect cells. J. Struct. Funct. Genomics (2005) 6(2-3):189-194.
37. SUMMERS MD: Milestones leading to the genetic engineering of baculoviruses as expression vector systems and viral pesticides. Adv. Virus Res. (2006) 68:3-73.
38. HARTLEY JL, TEMPLE GF, BRASCH MA: DNA cloning using in vitro site-specific recombination. Genome Res. (2000) 10(11):1788-1795.
39. KACHEL V, SINDELAR G, GRIMM S: High-throughput isolation of ultra-pure plasmid DNA by a robotic system. BMC Biotech. (2006) 6:9.
40. DAVIES A, GREENE A, LULLAU E, ABBOTT WM: Optimisation and evaluation of a high-throughput mammalian protein expression system. Protein Expr. Purif. (2005) 42(1):111-121.
41. YOUNG AT, MOORE RB, MURRAY AG, MULLEN JC, LAKEY JR: Assessment of different transfection parameters in efficiency optimization. Cell Transplant. (2004) 13(2):179-185.
42. PAGANO JS, VAHERI A: Enhancement of infectivity of poliovirus RNA with diethylaminoethyl-dextran (DEAE-D). Arch. Gesamte. Virusforsch. (1965) 17(3):456-464
43. SCHENBORN ET, GOIFFON V: DEAE-dextran transfection of mammalian cultured cells. Methods Mol. Biol. (2000) 130:147-153.
44. FELGNER PL, GADEK TR, HOLM M et al.: Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA (1987) 84(21):413-417.
45. FARHOOD H, SERBINA N, HUANG L: The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim. Biophys. Acta (1995) 1235(2):289-295.
46. HUI SW, LANGNER M, ZHAO YL, ROSS P, CHAN K: The role of helper lipids in cationic liposome-mediated gene transfer. Biophys. J. (1996) 71(2):590-599.
47. WROBEL I, COLLINS D: Fusion of cationic liposomes with mammalian cells occurs after endocytosis. Biochim. Biophys. Acta (1995) 1235(2):296-304.
48. FRIEND DS, PAPAHADJOPOULOS D, DEBS RJ: Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. Biochim. Biophys. Acta (1996) 1278(1):41-50.
49. GAO X, HUANG L: Cationic liposome-mediated gene transfer. Gene Ther. (1995) 2(10):710-722.
50. BEHR JP: The proton sponge: a trick to enter cells the viruses did not exploit. Chimia (1997) 51:34-36.
51. + progenitor cells can avoid induction of interferon responses to siRNAs in vitro. Nat. Biotechnol. (2006) 24(5):566-571.
52. SIOUD M: Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J. Mol. Biol. (2005) 348(5):1079-1090.
53. ROMANO DM, DONG Y, HILTUNEN M, TANZI RE, XIE Z: Artefactual effects of lipid-based cell transfection reagents on AβPP processing and Aβ production. Amyloid (2006) 13(2):86-92.
54. ESCRIOU V, CARRIERE M, SCHERMAN D, WILS P: NLS bioconjugates for targeting therapeutic genes to the nucleus. Adv. Drug Deliv. Rev. (2003) 55(2):295-306.
55. SUBRAMANIAN A, RANGANATHAN P, DIAMOND SL: Nuclear targeting peptide scaffold for lipofection of nondividing mammalian cells. Nat. Biotechnol. (1999) 17(9):873-877.
56. LECHARDEUR D, VERKMAN AS, LUKACS GL: Intracellular routing of plasmid DNA during non-viral gene transfer. Adv. Drug Deliv. Rev. (2005) 57(5):755-767.
57. BROKX R, GARIÉPY J: Peptide- and polymer-based gene delivery vehicles. In: Methods in Molecular Medicine (Volume 90). Springer CJ (Ed.), Human Press, Inc., New Jersey (2004):139-160.
58. DEMENEIX B, BEHR JP: Polyethylenimine (PEI). In: Advances in Genetics, Nonviral Vectors for Gene Therapy (Volume 53). Hung, Wagner, Huang (Eds), Elsevier (2005):217-230.
59. MAHATO RI: Water insoluble and soluble lipids for gene delivery. Adv. Drug Deliv. Rev. (2005) 57(5):699-712.
60. NEU M, FISCHER D, KISSEL T: Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J. Gene Med. (2005) 7(8):992-1009.
61. ZHANG X, GODBEY WT: Viral vectors for gene delivery in tissue engineering. Adv. Drug Deliv. Rev. (2006) 58(4):515-534.
62. ZHAO W, KOBAYASHI M, HOSOKAWA M, SETH P: Adenoviral vectors for cancer gene therapy. Curr. Genomics (2002)3:163-180.
63. LOTZE MT, KOST TA: Viruses as gene delivery vectors: application to gene function, target validation, and assay development. Cancer Gene Ther. (2002) 9(8):692-699.
64. MAH C, BYRNE BJ, FLOTTE TR: Virus-based gene delivery systems. Clin. Pharmacokinet. (2002) 41(12):901-911.
65. MARSHALL E: Gene therapy death prompts review of adenovirus vector. Science (1999) 286(5448):2244-2245.
66. CARTER BJ: Adeno-associated virus vectors in clinical trials. Hum. Gene Ther. (2005) 16(5):541-550.
67. GELLER SF, GE PS, VISEL M, GREENBERG KP, FLANNERY JG: Functional promoter testing using a modified lentiviral transfer vector. Mol. Vis. (2007) 13:730-739.
68. BARTOSCH B, COSSET FL: Strategies for retargeted gene delivery using vectors derived from lentiviruses. Curr. Gene Ther. (2004) 4(4):427-443.
69. DALY TM: Overview of adeno-associated viral vectors. In: Methods in Molecular Biology (Volume 246). Heiser WC (Ed.), Human Press, Inc., New Jersey (2004):157-165.
70. FAVARD C, DEAN DS, ROLS MP: Electrotransfer as a non viral method of gene delivery. Curr. Gene Ther. (2007) 7(1):67-77.
71. HELLER LC, UGEN K, HELLER R: Electroporation for targeted gene transfer. Expert Opin. Drug Deliv. (2005) 2(2):255-268.
72. GRESCH O, ENGEL FB, NESIC D et al.: New non-viral method for gene transfer into primary cells. Methods (2004) 33(2):151-163.
73. ZEITELHOFER M, VESSEY JP, XIE Y et al.: High-efficiency transfection of mammalian neurons via nucleofection. Nat. Protoc. (2007) 2(7):1692-1704.
74. GAO X, KIM KS, LIU D: Nonviral gene delivery: what we know and what is next. AAPS J. (2007) 9(1):E92-E104.
75. MEHIER-HUMBERT S, GUY RH: Physical methods for gene transfer: improving the kinetics of gene delivery into cells. Adv. Drug Deliv. Rev. (2005) 57(5):733-753.
76. SCHERER F, ANTON M, SCHILLINGER U et al.: Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. (2002) 9(2):102-109.
77. TSUKAKOSHI M, KURATA S, NOMIYA Y, IKAWA Y, KASUYA T: A novel method of DNA transfection by laser microbeam cell surgery. Appl. Phys. B. (1984) 35:1-6.
78. CLARK IB. HANANIA EG, STEVENS J et al.: Optoinjection for efficient targeted delivery of a broad range of compounds and macromolecules into diverse cell types. J. Biomed. Opt. (2006) 11(1):014034.
79. CESNULEVICIUS K, TIMMER M, WESEMANN M, THOMAS T, BARKHAUSEN T, GROTHE C: Nucleofection is the most efficient non-viral transfection method for neuronal stem cells derived from ventral mesencephali with no changes in cell composition or dopaminergic fate. Stem Cells (2006) 24(12):2776-2791.
80. HAGEMANN C, MEYER C, STOJIC J et al.: High efficiency transfection of glioma cell lines and primary cells for overexpression and RNAi experiments. J. Neurosci. Methods (2006) 156(1-2):194-202.
81. HU MC, LEE DF, XIA W et al.: IκB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell (2004) 117(2):225-237.
82. LECLERE PG, PANJWANI A, DOCHERTY R, BERRY M, PIZZEY J, TONGE DA: Effective gene delivery to adult neurons by a modified form of electroporation. J. Neurosci. Methods (2005) 142(1):137-143.
83. SIEMEN H, NIX M, ENDL E, KOCH P, ITSKOVITZ-ELDOR J, BRÜSTLE O: Nucleofection of human embryonic stem cells. Stem Cells Dev. (2005) 14(4):378-383.
84. LENZ P, BACOT SM, FRAZIER-JESSEN MR, FELDMAN GM: Nucleoporation of dendritic cells: efficient gene transfer by electroporation into human monocyte-derived dendritic cells. FEBS Lett. (2003) 538(1-3):149-154.
85. TROMPETER HI, WEINHOLD S, THIEL C, WERNET P, UHRBERG M: Rapid and highly efficient gene transfer into natural killer cells by nucleofection. J. Immunol. Methods (2003) 274(1-2):245-256.
86. MOUSSES S, CAPLEN NJ, CORNELISON R et al.: RNAi microarray analysis in cultured mammalian cells. Genome Res. (2003) 13(10):2341-2347.
87. KUMAR R, CONKLIN DS, MITTAL V: High-throughput selection of effective RNAi probes for gene silencing. Genome Res. (2003) 13(10):2333-2340.
88. OVCHARENKO D, JARVIS R, HUNICKE-SMITH S, KELNAR K, BROWN D: High-throughput RNAi screening in vitro: from cell lines to primary cells. RNA (2005) 11(6):985-993.
89. PADDISON PJ, SILVA JM, CONKLIN DS et al.: A resource for large-scale RNAi-interference-based screens in mammals. Nature (2004) 428(6981):427-431.
90. BERNS K, HIJMANS EM, MULLENDERS J et al.: A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature (2004) 428:431-437.
91. STEWART SA, DYKXHOORN DM, PALLISER D et al.: Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA (2003) 9(4):493-501.
92. ZUFFEREY R, DULL T, MANDEL RJ et al.: Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. (1998) 72(12):9873-9880.
93. ZUFFEREY R, NAGY D, MANDEL RJ, NALDINI L, TRONO D: Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. (1997) 15(9):871-875.
94. MIZUGUCHI H, HAYAKAWA T: Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes. Gene (2002) 285(1-2):69-77.
95. BUCHSER WJ, PARDINAS JR, SHI Y, BIXBY JL, LEMMON VP: 96-well electroporation method for transfection of mammalian central neurons. Biotechniques (2006) 41(5):619-624.
96. 2 receptor-transfected SH-SY5Y neuroblastoma cells. Mol. Pharmacol. (2005) 67(3):965-975.
97. Tecan J. (2007) 2:9-11.
98. Nat. Methods (2006) 3(9):(Entire Issue).
99. BANDYOPADHYAY S, NI J, RUGGIERO A et al.: A high-throughput drug screen targeted to the 5′untranslated region of Alzheimer amyloid precursor protein mRNA. J. Biomol. Screen. (2006) 11(5):469-480.
100. VAN BAALEN CA, KWA D, VERSCHUREN EJ et al.: Fluorescent antigen-transfected target cell cytotoxic T lymphocyte assay for ex vivo detection of antigen-specific cell-mediated cytotoxicity. J. Infect. Dis. (2005) 192(7):1183-1190.
101. VO N, KLEIN ME, VARLAMOVA O et al.: A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc. Natl. Acad. Sci. USA (2005) 102(45):16426-16431.
102. BUTLER M: Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals. Appl. Microbiol. Biotechnol. (2005) 68(3):283-291.
103. WURM FM: Production of recombinant protein therapeutics in cultivated mammalian cells. Nat. Biotechnol. (2004) 22(11):1393-1398.
104. FERRARI S, PELLEGRINI C, MATSUI T, MAVILIO M, DE LUCA M: Gene therapy in combination with tissue engineering to treat epidermolysis bullosa. Expert Opin. Biol. Ther. (2006) 6(4):367-378.
105. TEY SK, BOLLARD CM, HESLOP HE: Adoptive T-cell transfer in cancer immunotherapy. Immunol. Cell Biol. (2006) 84(3):281-289.
106. FEDOROV Y, KING A, ANDERSON E et al.: Different delivery methods - different expression profiles. Nat. Methods (2005) 2(4):241.
107. DU Z, KELLY E, MECKLENBRÄUKER I et al.: Selective regulation of IL-10 signaling and function by zymosan. J. Immunol. (2006) 176(8):4785-4792.